Hepatitis C testing and treatment among active drug users in Amsterdam-Reference-Cited by-同舟云学术

Hepatitis C testing and treatment among active drug users in Amsterdam

Published:2011-01 Issue:1 Volume:23 Page:23-31
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Lindenburg Catharina E.A.,Lambers Femke A.E.,Urbanus Anouk T.,Schinkel Janke,Jansen Peter L.M.,Krol Anneke,Casteelen Gerty,van Santen Gerrit,van den Berg Charlotte H.S.B.,Coutinho Roel A.,Prins Maria,Weegink Christine J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference51 articles.

1. Global estimates of prevalence of HCV infection among injecting drug users

2. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. Rate and predictors of treatment prescription for hepatitis C

5. Limited Uptake of Hepatitis C Treatment Among Injection Drug Users

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico;Journal of Substance Use and Addiction Treatment;2024-05

2. Experiences of Hope after Treatment of Hepatitis C Infection—A Qualitative Study;International Journal of Environmental Research and Public Health;2022-11-26

3. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study;International Journal of Drug Policy;2022-04

4. A Feasibility Study to Increase Chronic Hepatitis C Virus RNA Testing and Linkage to Care among Clients Attending Homeless Services in Amsterdam, The Netherlands;Diagnostics;2021-06-30

5. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV);PLOS Medicine;2021-06-01